Comparative gender analysis of the efficacy and safety of atazanavir/ritonavir and lopinavir/ritonavir at 96 weeks in the CASTLE study

por Squires, Kathleen E., Johnson, Margaret, Yang, Rong, Uy, Jonathan, Sheppard, Louise, Absalon, Judith, McGrath, Donnie
Publicado 2011

Awareness, Knowledge, and Perceptions of Biosimilars Among Specialty Physicians

por Cohen, Hillel, Beydoun, Donna, Chien, David, Lessor, Tracy, McCabe, Dorothy, Muenzberg, Michael, Popovian, Robert, Uy, Jonathan
Publicado 2016

Virologic Failures on Initial Boosted-PI Regimen Infrequently Possess Low-Level Variants with Major PI Resistance Mutations by Ultra-Deep Sequencing

por Lataillade, Max, Chiarella, Jennifer, Yang, Rong, DeGrosky, Michelle, Uy, Jonathan, Seekins, Daniel, Simen, Birgitte, St. John, Elizabeth, Moreno, Elizabeth, Kozal, Michael
Publicado 2012

Effectiveness of Guselkumab Therapy among Patients with Plaque Psoriasis with Baseline IGA Score ≥ 2 in the CorEvitas Psoriasis Registry

por Armstrong, April W., Fitzgerald, Timothy, McLean, Robert R., Teeple, Amanda, Uy, Jonathan P., Olurinde, Mobolaji, Rowland, Katelyn, Guo, Lin, Shan, Ying, Callis Duffin, Kristina
Publicado 2022

Real-World Effectiveness of 9–12 Months of Guselkumab Therapy among Patients with Moderate-to-Severe Plaque Psoriasis in the CorEvitas Psoriasis Registry

por Armstrong, April W., Fitzgerald, Timothy, McLean, Robert R., Teeple, Amanda, Uy, Jonathan P., Olurinde, Mobolaji, Rowland, Katelyn, Guo, Lin, Shan, Ying, Callis Duffin, Kristina
Publicado 2022

Prevalence and Clinical Significance of HIV Drug Resistance Mutations by Ultra-Deep Sequencing in Antiretroviral-Naïve Subjects in the CASTLE Study

por Lataillade, Max, Chiarella, Jennifer, Yang, Rong, Schnittman, Steven, Wirtz, Victoria, Uy, Jonathan, Seekins, Daniel, Krystal, Mark, Mancini, Marco, McGrath, Donnie, Simen, Birgitte, Egholm, Michael, Kozal, Michael
Publicado 2010

Demographics, Disease Characteristics, and Patient-Reported Outcomes Among Patients with Psoriasis Who Initiated Guselkumab in CorEvitas’ Psoriasis Registry

por Walsh, Jessica A., Callis Duffin, Kristina, Van Voorhees, Abby S., Chakravarty, Soumya D., Fitzgerald, Timothy, Teeple, Amanda, Rowland, Katelyn, Uy, Jonathan, McLean, Robert R., Malley, Wendi, Cronin, Angel, Merola, Joseph F.
Publicado 2021

Signal Detection and Methodological Limitations in a Real-World Registry: Learnings from the Evaluation of Long-Term Safety Analyses in PSOLAR

por Bissonnette, Robert, Gottlieb, Alice B., Langley, Richard G., Leonardi, Craig L., Papp, Kim A., Pariser, David M., Uy, Jonathan, Lafferty, Kim Parnell, Langholff, Wayne, Fakharzadeh, Steven, Berlin, Jesse A., Brouwer, Emily S., Greenspan, Andrew J., Strober, Bruce E.
Publicado 2021

Efficacy and Safety of Three Antiretroviral Regimens for Initial Treatment of HIV-1: A Randomized Clinical Trial in Diverse Multinational Settings

por Campbell, Thomas B., Smeaton, Laura M., Kumarasamy, N., Flanigan, Timothy, Klingman, Karin L., Firnhaber, Cynthia, Grinsztejn, Beatriz, Hosseinipour, Mina C., Kumwenda, Johnstone, Lalloo, Umesh, Riviere, Cynthia, Sanchez, Jorge, Melo, Marineide, Supparatpinyo, Khuanchai, Tripathy, Srikanth, Martinez, Ana I., Nair, Apsara, Walawander, Ann, Moran, Laura, Chen, Yun, Snowden, Wendy, Rooney, James F., Uy, Jonathan, Schooley, Robert T., De Gruttola, Victor, Hakim, James Gita
Publicado 2012